To use all functions of this page, please activate cookies in your browser.
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
DuPont Tate & Lyle Bio Products Announces New President
Todd Sutton has been Appointed President of DuPont Tate & Lyle Bio Products
05-04-2012: DuPont Tate & Lyle Bio Products announced that Todd Sutton has been appointed president of DuPont Tate & Lyle Bio Products LLC. DuPont Tate & Lyle Bio Products is a joint venture formed in 2004 between DuPont and Tate & Lyle.
A 28-year veteran of DuPont, Todd brings a wealth of business and market expertise to this leadership role. Previously, he was vice president at Liqui-Box, a packaging company acquired by DuPont. He also served as the global marketing director for the Solae™ soy protein business, a joint venture between DuPont and Bunge headquartered in St. Louis, Mo. Prior to that, Todd worked in the DuPont™ Corian® business where he held a range of sales, marketing and regional management positions in New York, Massachusetts, and Delaware. He spent 2-1/2 years in Hong Kong as the regional product manager before returning to the corporate headquarters in Delaware.
- 1Panspecific antibodies: Novimmune successful in multiple specificities
- 2Rosetta Resolver® Gene Expression Data Analysis System licensed by Aventis Pharmaceuticals, Inc.
- 3Protein 'bar code' in spinal fluid could lead to first diagnostic test for Alzheimer's patients, Cornell researchers say
- 47TM Pharma's new first-in-class anti-obesity drug completes Phase I/II clinical studies
- 5Pharmexa A/S sells Pharmexa-Epimmune to the Korean company VaxOnco, Inc.
- 6Pharma’s New Hero: Supergenerics Save Money and Improve Drugs
- 7Bayer’s Novel Anticoagulant Xarelto now also Approved in the EU
- 8Takara Bio to Acquire Clontech Unit of BD Biosciences
- 9Synthon enters into global license agreement with Amgen and Watson for biosimilar trastuzumab
- 10Michael Schlenk New Chief Executive Officer of Centogene Holding AG
- Bone Therapeutics Appoints Dr Guy Heynen as Chief Clinical and Regulatory Of ...
- Ablynx appoints Johan Heylen as Chief Commercial Officer
- Intercept Pharmaceuticals Appoints Lisa Bright as Head of Europe
- Sanofi and the Institut Pasteur reward four researchers for their influentia ...
- Horizon Discovery Group plc Appoints Dr David Smoller as an Executive Director
- Long-Term Testosterone Therapy Does Not Increase the Risk of Prostate Cancer
- SLU researcher finds an off switch for pain
- Thermo Fisher Scientific and Samsung Electronics to Collaborate on Point-of-Care Diagnostic Solutions
- Fat and bone marrow-derived stem cells combo shows promise in preventing transplant rejection
- AMRI Announces Albuquerque, N.M. Manufacturing Facility Fully Operational